Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 1Oligodendroglioma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 4abemaciclib 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2vorasidenib 1pembrolizumab 1Vorinostat 1Vincristine 1Specimen Handling 1Radiotherapy, Conformal 1Protons 1Proton Therapy 1Procarbazine 1OKN 007 1Nivolumab 1Magnetic Resonance Spectroscopy 1Lomustine 1Irinotecan 1DNA Methylation 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Biopsy 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oligodendroglioma × DNA Methylation × Clear all
NCT00626990 2023-09-11

CATNON

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
751 enrolled 18 charts
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡